http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7900806

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase III|Journal Article|Randomized Controlled Trial
endingPage 1649
issn 1532-1827
0007-0920
issueIdentifier 11
pageRange 1644-1649
publicationName British Journal of Cancer
startingPage 1644
bibliographicCitation Berghmans T, Lafitte JJ, Lecomte J, Alexopoulos CG, Van Cutsem O, Giner V, Efremidis A, Berchier MC, Collon T, Meert AP, Scherpereel A, Ninane V, Leclercq N, Paesmans M, Sculier JP, for the European Lung Cancer Working Party. Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party. British Journal of Cancer. 2007 May 01;96(11):1644–9. doi: 10.1038/sj.bjc.6603772.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66f68807cd1a0a2f86e7b5f836b33f92
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d3ca97c99f11ef65460ec6c6322289b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de59d55820a6b4f30912a14cee133345
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97129b2914b10936d38b37b117cb8fb7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f4d2a4117e10793cb31ffed743f5c4e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea0e629ae8347737df2848552566ab74
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e1e263ba01d42c374a32d23400c1284
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4563d018dee50d590887d651c47126da
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e241471188bfe9f9bcd65b75981704c1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcfa418aaa1be51b20d33f20acfdf897
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0139ae9b64a5f86d0b13d7daecb0291
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acf7de466250a246fc9c290c30d832c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad714e938f5afe03eb066b2c1d3544c5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6969cf770d0eb4cadd044a04da9cad02
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b96922a7a803fe600a3bdf5606d7e79
date 2007-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/sj.bjc.6603772
https://pubmed.ncbi.nlm.nih.gov/17473825
https://pubmed.ncbi.nlm.nih.gov/PMC2359915
isPartOf https://portal.issn.org/resource/ISSN/1532-1827
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
discusses http://id.nlm.nih.gov/mesh/M0010999
http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M000754277
http://id.nlm.nih.gov/mesh/M0026156
http://id.nlm.nih.gov/mesh/M0004505
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3690
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9710

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128090325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764

Total number of triples: 58.